Opus Genetics
€4.4
57
+€0.02+0.46% Today
Statistics
Day High
4.4
Day Low
4.4
52W High
4.47
52W Low
0.62
Volume
-
Avg. Volume
-
Mkt Cap
303.44M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-0.130236
Actual EPS
N/A
Financials
-527.61%Profit Margin
Unprofitable20.87MRevenue
-110.12MNet Income
Analyst Ratings
$8.02Average Price Target
The highest estimate is 11.38.
From 7 ratings within the last 6 months. This is not an investment recommendation.
From 7 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow R3X1.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
EyePoint
EYPT
Mkt Cap1.12B
Bausch Health Companies
BHC
Mkt Cap1.99B
Regeneron Pharmaceuticals
REGN
Mkt Cap80.54B
Novartis
NVS
Mkt Cap297.32B
GSK
GSK
Mkt Cap113.29B
Abbvie
ABBV
Mkt Cap369.39B
Pfizer
PFE
Mkt Cap161.09B
Regenxbio
RGNX
Mkt Cap440.26M
About
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.
Show more...
CEO
Dr. George Magrath M.B.A., M.D., M.S.
Employees
27
Country
DE
ISIN
US67577R1023
WKN
000A2QG4Z
Listings
0 Comments
Share your thoughts
FAQ
What is Opus Genetics stock price today?▼
The current price of R3X1.F is €4.4 EUR — it has increased by +0.46% in the past 24 hours. Watch Opus Genetics stock price performance more closely on the chart.
What is Opus Genetics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Opus Genetics stocks are traded under the ticker R3X1.F.
Is Opus Genetics stock price growing?▼
R3X1.F stock has risen by +12.82% compared to the previous week, the month change is a +8.11% rise, over the last year Opus Genetics has showed a +558.68% increase.
What is Opus Genetics market cap?▼
Today Opus Genetics has the market capitalization of 303.44M
When is the next Opus Genetics earnings date?▼
Opus Genetics is going to release the next earnings report on May 08, 2026.
What were Opus Genetics earnings last quarter?▼
R3X1.F earnings for the last quarter are -0.16 EUR per share, whereas the estimation was -0.1 EUR resulting in a -70% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Opus Genetics revenue for the last year?▼
Opus Genetics revenue for the last year amounts to 20.87M EUR.
What is Opus Genetics net income for the last year?▼
R3X1.F net income for the last year is -110.12M EUR.
How many employees does Opus Genetics have?▼
As of April 09, 2026, the company has 27 employees.
In which sector is Opus Genetics located?▼
Opus Genetics operates in the Health Care sector.
When did Opus Genetics complete a stock split?▼
The last stock split for Opus Genetics was on November 06, 2020 with a ratio of 1:4.
Where is Opus Genetics headquartered?▼
Opus Genetics is headquartered in Durham, DE.